These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11103915)

  • 21. Light-enhanced startle: further pharmacological and behavioral characterization.
    Walker DL; Davis M
    Psychopharmacology (Berl); 2002 Jan; 159(3):304-10. PubMed ID: 11862363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anxiogenic treatments do not increase fear-potentiated startle in mice.
    Risbrough VB; Geyer MA
    Biol Psychiatry; 2005 Jan; 57(1):33-43. PubMed ID: 15607298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time course of discriminative stimulus effects of bretazenil and chlordiazepoxide in rats.
    Bronson M; Chen HC
    Eur J Pharmacol; 1996 Jun; 305(1-3):7-12. PubMed ID: 8813525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diazepam and flurazepam: effects on conditioned fear as measured with the potentiated startle paradigm.
    Davis M
    Psychopharmacology (Berl); 1979 Mar; 62(1):1-7. PubMed ID: 35808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates.
    Atack JR; Wafford KA; Tye SJ; Cook SM; Sohal B; Pike A; Sur C; Melillo D; Bristow L; Bromidge F; Ragan I; Kerby J; Street L; Carling R; Castro JL; Whiting P; Dawson GR; McKernan RM
    J Pharmacol Exp Ther; 2006 Jan; 316(1):410-22. PubMed ID: 16183706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuation of the bidirectional effects of chlordiazepoxide and FG 7142 on conditioned response suppression and associated cardiovascular reactivity by loss of cortical cholinergic inputs.
    Stowell JR; Berntson GG; Sarter M
    Psychopharmacology (Berl); 2000 Jun; 150(2):141-9. PubMed ID: 10907667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of oxytocin on background anxiety in rats with high or low baseline startle.
    Ayers L; Agostini A; Schulkin J; Rosen JB
    Psychopharmacology (Berl); 2016 Jun; 233(11):2165-2172. PubMed ID: 27004789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benzodiazepines have no effect on fear-potentiated startle in humans.
    Baas JM; Grillon C; Böcker KB; Brack AA; Morgan CA; Kenemans JL; Verbaten MN
    Psychopharmacology (Berl); 2002 May; 161(3):233-47. PubMed ID: 12021826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fear-potentiated startle response is remarkably similar in two laboratories.
    Joordens RJ; Hijzen TH; Peeters BW; Olivier B
    Psychopharmacology (Berl); 1996 Jul; 126(2):104-9. PubMed ID: 8856828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The light-enhanced startle paradigm as a putative animal model for anxiety: effects of chlordiazepoxide, flesinoxan and fluvoxamine.
    de Jongh R; Groenink L; van Der Gugten J; Olivier B
    Psychopharmacology (Berl); 2002 Jan; 159(2):176-80. PubMed ID: 11862346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic bretazenil produces tolerance to chlordiazepoxide, midazolam, and abecarnil.
    Bronson ME
    Pharmacol Biochem Behav; 1995; 51(2-3):481-90. PubMed ID: 7667373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative cue generalization profiles of L-838, 417, SL651498, zolpidem, CL218,872, ocinaplon, bretazenil, zopiclone, and various benzodiazepines in chlordiazepoxide and zolpidem drug discrimination.
    Mirza NR; Rodgers RJ; Mathiasen LS
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1291-9. PubMed ID: 16339395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct contributions of median raphe nucleus to contextual fear conditioning and fear-potentiated startle.
    Silva RC; Cruz AP; Avanzi V; Landeira-Fernandez J; Brandão ML
    Neural Plast; 2002; 9(4):233-47. PubMed ID: 12959153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lasting effect of repeated cocaine administration on acoustic and fear-potentiated startle in rats.
    Gordon MK; Rosen JB
    Psychopharmacology (Berl); 1999 May; 144(1):1-7. PubMed ID: 10379618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Olfactory-mediated fear-potentiated startle.
    Paschall GY; Davis M
    Behav Neurosci; 2002 Feb; 116(1):4-12. PubMed ID: 11895182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A further investigation of the developmental emergence of fear-potentiated startle in rats.
    Hunt PS
    Dev Psychobiol; 1999 May; 34(4):281-91. PubMed ID: 10331152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effects of alprazolam on the baseline and fear-potentiated startle reflex in humans: a dose-response study.
    Riba J; Rodríguez-Fornells A; Urbano G; Morte A; Antonijoan R; Barbanoj MJ
    Psychopharmacology (Berl); 2001 Oct; 157(4):358-67. PubMed ID: 11605094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological modulation of conditioned fear in the fear-potentiated startle test: a systematic review and meta-analysis of animal studies.
    Groenink L; Verdouw PM; Zhao Y; Ter Heegde F; Wever KE; Bijlsma EY
    Psychopharmacology (Berl); 2023 Nov; 240(11):2361-2401. PubMed ID: 36651922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats.
    Knoll AT; Meloni EG; Thomas JB; Carroll FI; Carlezon WA
    J Pharmacol Exp Ther; 2007 Dec; 323(3):838-45. PubMed ID: 17823306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fear-Conditioning to Unpredictable Threats Reveals Sex and Strain Differences in Rat Fear-Potentiated Startle (FPS).
    Olivera-Pasilio V; Dabrowska J
    Neuroscience; 2023 Oct; 530():108-132. PubMed ID: 37640137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.